1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with gadolinium in 3 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (gadolinium) | Trials (gadolinium) | Recent Studies (post-2010) (gadolinium) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 13,838 | 519 | 6,282 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Levine, BA; McCollum, MO; Olson, MS; Zhou, W | 1 |
Bartha, K; Jenei, B; Lázár, G; Medgyesi, GA | 1 |
Arese, M; Bargnani, C; Bussolino, F; Callea, L; Orlandini, A; Priori, A | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and gadolinium
Article | Year |
---|---|
Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion.
Topics: Alanine Transaminase; Allopurinol; Animals; Azepines; Gadolinium; Hepatitis; Ischemia; Leukocytes; Liver; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Triazoles | 1992 |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function).
Topics: Animals; Captopril; Diterpenes; Female; Gadolinium; Ginkgolides; Hypotension; Immunoglobulin G; Kupffer Cells; Lactones; Macromolecular Substances; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1991 |
Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood-Brain Barrier; Capillaries; Child; Disease Progression; Female; Gadolinium; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence | 1999 |